ARCB vs RHI

ARCB exhibits a severe decoupling between its market price and fundamental value, with a Piotroski F-Score of 4/9 indicating only stable to weak financial health. The stock is trading at $127.76, which is significantly above both its Graham Number ($56.42) and its growth-based Intrinsic Value ($17.08). Despite a massive 117% one-year price surge, the company is facing negative revenue growth (-2.90%) and a sharp decline in YoY EPS (-37.3%). The current valuation is unsustainable given the razor-thin operating margins (0.42%) and deteriorating earnings trend.

RHI exhibits severe fundamental weakness, highlighted by a Piotroski F-Score of 2/9, indicating poor financial health. The stock is significantly overvalued relative to its Graham Number ($19.38) and Intrinsic Value ($9.10), while trading at a prohibitive PEG ratio of 5.46. Revenue and earnings are in a clear downward trajectory, and the current dividend payout ratio of 181.76% is mathematically unsustainable. Technical trends are completely bearish (0/100), suggesting a lack of buyer conviction despite the high yield.